Evidence map›Paper›PMID 32650781›Full record

ArticleHealth and quality of life outcomes2020

Assessing the psychometric properties of the French WHOQOL-HIV BREF within the ANRS CO3 Aquitaine Cohort's QuAliV ancillary study.

Diana Barger, Mojgan Hessamfar, Didier Neau, Marc-Olivier Vareil, Estibaliz Lazaro, Pierre Duffau, Nicolas Rouanes, Olivier Leleux, Fabien Le Marec, Marie Erramouspe and 3 more

Registry-linked trialOpen access · goldAbstract readValidation Study
In one paragraph

Article in Health and quality of life outcomes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03296202 (Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03296202 active not recruitingnot on this map

Risk of Morbidity, Mortality and Long-term Monitoring of Antiretroviral Treatment in People Living With HIV: The ANRS CO3 Aquitaine Cohort - AquiVIH-NA

TypeobservationalSponsorUniversity Hospital, BordeauxRan2017 to 2026Enrolled7,500ConditionsHIV Infections, Antiretroviral Agents
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Diana BargerUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France. diana.barger@u-bordeaux.fr.ORCID http://orcid.org/0000-0001-8491-3963
Mojgan HessamfarUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France.
Didier NeauService de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Bordeaux (CHU), F-33000, Bordeaux, France.
Marc-Olivier VareilService de Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Bordeaux (CHU), F-33000, Bordeaux, France.
Estibaliz LazaroServices de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Bordeaux (CHU), F-33000, Bordeaux, France.
Pierre DuffauServices de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Bordeaux (CHU), F-33000, Bordeaux, France.
Nicolas RouanesCentre Hospitalier de de Périgueux, F-24000, Périgueux, France.
Olivier LeleuxUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France.
Fabien Le MarecUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France.
Marie ErramouspeAIDES Nouvelle Aquitaine, Bordeaux, France.
Linda WittkopUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France.
François DabisUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France.
Fabrice BonnetUniv Bordeaux, ISPED, Inserm Bordeaux Population Health, team MORPH3EUS, UMR 1219, CIC-EC 1401, F-33000, Bordeaux, France.
Université de Bordeaux · FRCentre Hospitalier Universitaire de Bordeaux · FRAgence Régionale de Santé Nouvelle-Aquitaine · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntiretroviral therapy has prolonged the lives of those with human immunodeficiency virus (HIV), but the effects of chronic infection on their health-related quality of life (HRQoL) remain a concern. Numerous instruments have been developed to measure HRQoL, yet evidence of their cross-cultural equivalence and continued applicability is limited. We adapted the WHOQOL-HIV BREF to French and assessed its psychometric properties in a sample of community-dwelling adults living with HIV who were mostly virally suppressed.

methodsWe conducted a cross-sectional study within the ANRS CO3 Aquitaine cohort from July 2018 to May 2019. Five hundred eighty-six participants were consecutively enrolled at their HIV-consultations and completed either a web-based (n = 406) or paper self-administered assessment (n = 180). The means and standard deviations for items and domains were computed and the presence of floor and ceiling effects assessed. We evaluated internal consistency by calculating Cronbach's alpha coefficients per domain. We assessed construct validity by performing a Confirmatory Factor Analysis (CFA). Concurrent, convergent and discriminant validity were assessed with Pearson's correlations and known-group validity was assessed according to CD4 cell count, viral load, Centers for Disease Control and Prevention clinical categories for HIV, and hospitalization of more than 48 h within 2 years of the most recent consultation using one-way analysis of variance and independent t-tests.

resultsFive hundred eighty-six PLWH were included in this analysis. Their median age was 55; 73% were male; 85% were of French descent; 99% were on ART and 93% were virally suppressed. We found floor effects for one and ceiling effects for 11 items. Four of the six domains showed good internal consistency (α range: 0.63-0.79). CFA showed that the WHOQOL-HIV BREF's six-domain structure produced an acceptable fit (SRMR = 0.059; CFI = 0.834; RMSEA = 0.07; 90% CI: 0.06-0.08). It showed good concurrent, convergent and discriminant validity. There was some evidence of known-group validity. The personal beliefs domain had the highest score (15.04 ± 3.35) and the psychological health domain had the lowest (13.70 ± 2.78).

conclusionsThe French WHOQOL-HIV BREF has acceptable measurement properties. Its broad conceptualisation of HRQoL, going beyond physical and mental health, may be of particular value in our older, treatment-experienced and virally suppressed population.

trial registrationClinicalTrials.gov NCT03296202 (Archived by WebCite at http://www.webcitation.org/6zgOBArps ).

Indexed as

Quality of LifeCross-Sectional StudiesFactor Analysis, StatisticalFemaleFranceHIV InfectionsHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesPsychometricsReproducibility of ResultsSurveys and QuestionnairesTranslationsHealth-related quality of lifeHIVWHOQOL-HIV BREF

Identifiers

PMID32650781
PMCPMC7350695
OpenAlexW3042068049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.